RT Journal Article
SR Electronic
T1 Correction: <em>Phase 2 study of pembrolizumab in patients with advanced rare cancers</em>
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000347corr1
DO 10.1136/jitc-2019-000347corr1
VO 8
IS 1
YR 2020
UL http://jitc.bmj.com/content/8/1/e000347corr1.abstract